Xiang Ao

6.0k total citations · 3 hit papers
96 papers, 4.4k citations indexed

About

Xiang Ao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiang Ao has authored 96 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 33 papers in Cancer Research and 18 papers in Oncology. Recurrent topics in Xiang Ao's work include Circular RNAs in diseases (25 papers), RNA modifications and cancer (19 papers) and Cancer-related molecular mechanisms research (18 papers). Xiang Ao is often cited by papers focused on Circular RNAs in diseases (25 papers), RNA modifications and cancer (19 papers) and Cancer-related molecular mechanisms research (18 papers). Xiang Ao collaborates with scholars based in China, United States and Hong Kong. Xiang Ao's co-authors include Ying Liu, Jianxun Wang, Wei Ding, Wanpeng Yu, Liyun Zou, Yuzhang Wu, Tao Xu, I H Russo, J. Russo and Xiaoyu Ji and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiang Ao

92 papers receiving 4.4k citations

Hit Papers

Molecular mechanisms of ferroptosis and its role in cance... 2018 2026 2020 2023 2019 2018 2022 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Molecular mechanisms of ferroptosis and its role in cancer therapy
    2019 493 citations Tao Xu, Wei Ding et al. profile →
  2. Critical role of FOXO3a in carcinogenesis
    2018 362 citations Ying Liu, Xiang Ao et al. Molecular Cancer profile →
  3. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer
    2022 276 citations Weijun Wan, Xiang Ao et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiang Ao China 35 3.0k 1.6k 724 699 483 96 4.4k
Benjamin D. Hopkins United States 26 3.0k 1.0× 940 0.6× 979 1.4× 576 0.8× 331 0.7× 44 4.5k
Xianghui Fu China 36 2.4k 0.8× 1.3k 0.8× 710 1.0× 474 0.7× 502 1.0× 103 4.1k
Sankar Addya United States 34 2.4k 0.8× 1.4k 0.8× 1.1k 1.5× 361 0.5× 291 0.6× 106 4.2k
Yangfu Jiang China 31 2.7k 0.9× 1.2k 0.8× 1.1k 1.6× 456 0.7× 415 0.9× 70 4.9k
Jie Zhou China 42 2.9k 1.0× 2.2k 1.3× 784 1.1× 387 0.6× 473 1.0× 104 5.0k
Gang Yin China 28 3.2k 1.1× 1.6k 1.0× 863 1.2× 412 0.6× 248 0.5× 100 4.6k
Richard Possemato United States 26 4.1k 1.4× 1.9k 1.2× 832 1.1× 892 1.3× 319 0.7× 40 5.5k
Yang‐Sook Chun South Korea 33 2.1k 0.7× 1.5k 0.9× 682 0.9× 298 0.4× 373 0.8× 68 3.6k

Countries citing papers authored by Xiang Ao

Since Specialization
Citations

This map shows the geographic impact of Xiang Ao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang Ao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang Ao more than expected).

Fields of papers citing papers by Xiang Ao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiang Ao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang Ao. The network helps show where Xiang Ao may publish in the future.

Co-authorship network of co-authors of Xiang Ao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiang Ao. A scholar is included among the top collaborators of Xiang Ao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiang Ao. Xiang Ao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Qingling, Xinhui Chen, Chenchen Zhao, et al.. (2025). Vascular Endothelial Growth Factor‐Mimetic Peptide and Mitochondria‐Targeted Antioxidant‐Loaded Hydrogel System Improves Repair of Myocardial Infarction in Mice. Journal of Biomedical Materials Research Part A. 113(5). e37924–e37924. 1 indexed citations
2.
Fang, Xinyu, Xiang Ao, Dandan Xiao, et al.. (2024). Circular RNA-circPan3 attenuates cardiac hypertrophy via miR-320-3p/HSP20 axis. Cellular & Molecular Biology Letters. 29(1). 3–3. 12 indexed citations
3.
4.
Ao, Xiang, Wei Ding, Xiaoge Li, et al.. (2023). Non-coding RNAs regulating mitochondrial function in cardiovascular diseases. Journal of Molecular Medicine. 101(5). 501–526. 50 indexed citations
5.
6.
Liu, Ying, et al.. (2022). FOXO3a in cancer drug resistance. Cancer Letters. 540. 215724–215724. 54 indexed citations
7.
Wan, Weijun, Xiang Ao, Quan Chen, et al.. (2022). METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer. Molecular Cancer. 21(1). 60–60. 276 indexed citations breakdown →
8.
Liu, Ying, et al.. (2022). Underlying mechanisms of epithelial splicing regulatory proteins in cancer progression. Journal of Molecular Medicine. 100(11). 1539–1556. 20 indexed citations
9.
Liu, Ying, et al.. (2021). Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer. Frontiers in Oncology. 11. 768918–768918. 33 indexed citations
10.
Guo, Wei, Wei Qiu, Xiang Ao, et al.. (2020). Low‐concentration DMSO accelerates skin wound healing by Akt/mTOR‐mediated cell proliferation and migration in diabetic mice. British Journal of Pharmacology. 177(14). 3327–3341. 28 indexed citations
11.
Ao, Xiang, et al.. (2019). Expression of SOX11 and HER2 and their association with recurrent breast cancer. Translational Cancer Research. 8(1). 248–254. 1 indexed citations
12.
Sun, Teng, Wei Ding, Tao Xu, et al.. (2019). Parkin Regulates Programmed Necrosis and Myocardial Ischemia/Reperfusion Injury by Targeting Cyclophilin-D. Antioxidants and Redox Signaling. 31(16). 1177–1193. 89 indexed citations
13.
Hu, Linjun, et al.. (2017). Modified docetaxel regimen for prostate cancer patients who got poor tolerance to chemotherapy. Zhonghua miniao waike zazhi. 38(8). 615–618. 1 indexed citations
14.
Wu, Huijian, Xiang Ao, Ying Liu, et al.. (2015). Association between EHBP1 rs721048(A>G) polymorphism and prostate cancer susceptibility: a meta-analysis of 17 studies involving 150,678 subjects. OncoTargets and Therapy. 8. 1671–1671. 8 indexed citations
15.
Zhao, Feng, Xiao‐Yan Bai, Hai-Lian Bi, et al.. (2015). DACH1 inhibits SNAI1-mediated epithelial–mesenchymal transition and represses breast carcinoma metastasis. Oncogenesis. 4(3). e143–e143. 70 indexed citations
16.
Ao, Xiang, Liyun Zou, & Yuzhang Wu. (2014). Regulation of autophagy by the Rab GTPase network. Cell Death and Differentiation. 21(3). 348–358. 323 indexed citations
17.
Peng, Weisheng, et al.. (2013). Inhibition of Rho-kinase alleviates peritoneal fibrosis and angiogenesis in a rat model of peritoneal dialysis. Renal Failure. 35(7). 958–966. 10 indexed citations
18.
Guo, Jingjing, Xiang Ao, Tianjun Zhou, et al.. (2012). Expression of CD133 in the tissue of locally advanced esophagus squamous cell cancer patients and its significance. Zhonghua shiyan waike zazhi. 29(3). 541–542. 1 indexed citations
19.
Russo, José, Mohamed H. Lareef, Quivo Tahin, et al.. (2002). 17β-Estradiol is carcinogenic in human breast epithelial cells. The Journal of Steroid Biochemistry and Molecular Biology. 80(2). 149–162. 67 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin D. Hopkins Breakdown of academic impact, for papers by Xianghui Fu Breakdown of academic impact, for papers by Sankar Addya Breakdown of academic impact, for papers by Yangfu Jiang Breakdown of academic impact, for papers by Jie Zhou Breakdown of academic impact, for papers by Gang Yin Breakdown of academic impact, for papers by Richard Possemato Breakdown of academic impact, for papers by Yang‐Sook Chun
Rankless by CCL
2026